相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Severe insulin resistance syndromes
Angeliki M. Angelidi et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Leptin in Leanness and Obesity JACC State-of-the-Art Review
Nikolaos Perakakis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study
Franck Boccara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Leptin alters energy intake and fat mass but not energy expenditure in lean subjects
Pavlina Chrysafi et al.
NATURE COMMUNICATIONS (2020)
Circulating profile of Activin-Follistatin-Inhibin Axis in women with hypothalamic amenorrhea in response to leptin treatment
Eirini Bouzoni et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Evinacumab in Patients with Refractory Hypercholesterolemia
Robert S. Rosenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naive of statin therapy: A cross-sectional analysis from the Swiss HIV cohort
Baris Gencer et al.
ATHEROSCLEROSIS (2019)
ANGPTL3 Inhibitors - Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism -
Eleni Geladari et al.
CIRCULATION JOURNAL (2019)
Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes
Eliza Christopoulou et al.
DISEASE MARKERS (2019)
Circulating levels of the components of the GH/IGF-1/IGFBPs axis total and intact IGF-binding proteins (IGFBP) 3 and IGFBP 4 and total IGFBP 5, as well as PAPPA, PAPPA2 and Stanniocalcin-2 levels are not altered in response to energy deprivation and/or metreleptin administration in humans
Eleni Pilitsi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention
Scott M. Grundy et al.
JAMA CARDIOLOGY (2019)
Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
Anna Cinkajzlova et al.
NUTRITION & DIABETES (2018)
Coronary Endothelial Dysfunction Is Associated With Elevated Serum PCSK9 Levels in People With HIV Independent of Low-Density Lipoprotein Cholesterol
Thorsten M. Leucker et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Cardiovascular Efficacy and Safety of PCSK9 Inhibitors: Systematic Review and Meta-analysis Including the ODYSSEY OUTCOMES Trial
Ricky D. Turgeon et al.
CANADIAN JOURNAL OF CARDIOLOGY (2018)
Inhibiting PCSK9-biology beyond LDL control
Robert M. Stoekenbroek et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Fatty Acid-Binding Protein 4-An Inauspicious Adipokine-In Serum and Urine of Post-Partum Women with Excessive Gestational Weight Gain and Gestational Diabetes Mellitus
Zaneta Kimber-Trojnar et al.
JOURNAL OF CLINICAL MEDICINE (2018)
The circulating metabolome of human starvation
Matthew L. Steinhauser et al.
JCI INSIGHT (2018)
Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy
Ranganath Muniyappa et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study
R. Kannan Mutharasan et al.
JOURNAL OF LIPID RESEARCH (2017)
A general introduction to adjustment for multiple comparisons
Shi-Yi Chen et al.
JOURNAL OF THORACIC DISEASE (2017)
Regulation of lipid metabolism by angiopoietin-like proteins
Wieneke Dijk et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients
Amy E. Levenson et al.
ENDOCRINOLOGY (2016)
Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause
Samar R. El Khoudary et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
The role of ANGPTL3 in controlling lipoprotein metabolism
Anna Tikka et al.
ENDOCRINE (2016)
PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver
Annie Demers et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
Xin-Lin Zhang et al.
BMC MEDICINE (2015)
HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export
Xian-Ming Du et al.
CIRCULATION RESEARCH (2015)
Metabolic functions of FABPs-mechanisms and therapeutic implications
Goekhan S. Hotamisligil et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes
M. Furkan Burak et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Lack of Day/Night variation in fibroblast growth factor 21 levels in young healthy men
J-P Foo et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Fibroblast Growth Factor 21 Levels in Young Healthy Females Display Day and Night Variations and Are Increased in Response to Short-Term Energy Deprivation Through a Leptin-Independent Pathway
Joo-Pin Foo et al.
DIABETES CARE (2013)
Peroxisome Proliferator-Activated Receptor-γ in Capillary Endothelia Promotes Fatty Acid Uptake by Heart During Long-Term Fasting
Kosaku Goto et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans
Lena Persson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Fasting reduces plasma proprotein convertase, subtilisin/kexin type 9 and cholesterol biosynthesis in humans
Jeffrey D. Browning et al.
JOURNAL OF LIPID RESEARCH (2010)
Pharmacokinetics of Subcutaneous Recombinant Methionyl Human Leptin Administration in Healthy Subjects in the Fed and Fasting States Regulation by Gender and Adiposity
Jean L. Chan et al.
CLINICAL PHARMACOKINETICS (2008)
Pharmacokinetics of recombinant methionyl human leptin after subcutaneous administration: Variation of concentration-dependent parameters according to assay
Jean L. Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy
Jennifer H. Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans
Jean L. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men
JL Chan et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin
GS Nagy et al.
CLINICAL INFECTIOUS DISEASES (2003)
Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction
JH Stein et al.
CIRCULATION (2001)
分享论文
